Table 1.
Mycotoxin | IEC model | Exposure Duration | Tested Exposure Concentration | Cytotoxicity Assay | LC50/Effective Concentration (ECs) | References |
---|---|---|---|---|---|---|
DON | Caco-2 (differentiated) | 24 h | 0, 1.39, 4.17, 12.5, 37.5 μM | LDH release | EC: 37.5 μM | [152] |
Caco-2 | 48 h | 0, 0.05, 0.1, 0.3, 0.5, 1, 3, 5, 10 μM | Luminescent Cell Viability Assay | LC50 =1.3 uM; EC: 0.5–10μM | [153] | |
Caco-2 | 24 h | 0, 0.25, 1, 2.5, 5, 10 μM | MTS Assay | LC50 = 10 μM | [154] | |
Neutral Red | LC50 = 3.7 μM | |||||
72 h | 0, 0.25, 1, 2.5, 5, 10 μM | MTS Assay | LC50 = 4.3 μM | |||
Neutral Red | LC50 = 3.7 μM | |||||
Caco-2 (differentiated) | 24 h | 0, 0.25, 1, 2.5, 5, 10 μM | MTS Assay | LC50 > 10 μM | [154] | |
Neutral Red | LC50 > 10 μM | |||||
72 h | 0, 0.25, 1, 2.5, 5, 10 μM | MTS Assay | LC50 > 10 μM | |||
Neutral Red | LC50 > 10 μM | |||||
Caco-2 | 72 h | 1–150 μM | Neutral Red | LC50 = 21.5 μM; EC: 10 μM | [155] | |
MTT Assay | LC50 = 25 μM; EC: 10 μM | |||||
Caco-2 | 24 h | 0, 0.001, 0.01, 0.1, 1, 10, 25, 50, 100 μM | CCK-8 | LC50 = 21.94 μM | [156] | |
48 h | LC50 = 9.39 μM | |||||
72 h | LC50 = 6.18 μM | |||||
IPEC-1 | 24 h | 0, 0.34, 0.67, 1.7, 3.4, 6.7 10.2, 13.4 μM | MTT Assay | EC: 1.7, 3.4, 10.2, 13.4 μM | [143] | |
48 h | EC: 0.34 μM; 1.7–13.4 μM | |||||
72 h | EC: 0.34 μM; 1.7- 13.4 μM | |||||
IPEC-1 (in serum-free media) | 24 h | 0, 0.67, 6.7 μM | LDH release | NA | ||
48 h | EC: 6.7 μM | |||||
72 h | EC: 6.7 μM | |||||
IPEC-1 (in complete media) | 24 h | 0, 0.67, 6.7 μM | Neutral Red | EC: 0.67, 6.7 μM | ||
48 h | EC: 6.7 μM | |||||
72 h | EC: 6.7 μM | |||||
IPEC-1 (in serum-free media) | 24 h | 0, 0.67, 6.7 μM | Neutral Red | EC: 0.67, 6.7 μM | ||
48 h | EC: 6.7 μM | |||||
72 h | EC: 6.7 μM | |||||
IPEC-J2 | 24 h | 0, 0.34, 0.67, 1.7, 3.4, 6.7 10.2, 13.4 μM | MTT Assay | EC: 0.34, 3.4, 6.7, 13.4 μM | [143] | |
48 h | EC: 1.7–13.4 μM | |||||
72 h | EC: 1.7–13.4 μM | |||||
14 d | 0, 0.17, 0.34, 0.67, 1.02, 1.34, 1.7 μM | 0.67, 1.02, 1.34, 1.7 μM | ||||
IPEC-J2 | 24 h | 0, 0.67, 6.7 μM | LDH release | NA | [143] | |
48 h | EC: 6.7 μM | |||||
72 h | NA | |||||
IPEC-J2 | 24 h | 0, 0.67, 6.7 μM | Neutral Red | EC: 0.67, 6.7 μM | [143] | |
48 h | EC: 6.7 μM | |||||
72 h | EC: 6.7 μM | |||||
IPEC-J2 (in serum-free media) | 24 h | 0, 0.67, 6.7 μM | Neutral Red | EC: 0.67, 6.7 μM | [143] | |
48 h | EC: 6.7 μM | |||||
72 h | EC: 6.7 μM | |||||
IPEC-J2 (basolateral) | 24 h | 0, 0.67, 1.7, 6.7, 13.4 μM | DAPI staining | NA | [157] | |
48 h | EC: 6.7, 13.4 μM | |||||
72 h | EC: 6.7, 13.4 μM | |||||
IPEC-J2 | 24 h | 0, 0.034, 0.085, 0.17, 0.34, 0.85, 1.7, 3.4, 17, 34 μM | Neutral Red | EC: 0.85–34 μM | [132] | |
IPEC-J2 | 72 h | 0, 3.4, 8.5, 17, 25.5, 34 μM | Annexin-V-FITC/ PI | EC: 8.5–34 μM | [158] | |
IPEC-J2 | 72 h | 0, 3.4, 17, 34, 51, 67 μM | Annexin-V-FITC/ PI | LC50 = 10.47 μM | [159] | |
IPEC-J2 (differentiated) | 72 h | 0, 3.4, 17, 34, 51, 67 μM | Annexin-V-FITC/ PI | LC50 = 46.9 μM | [159] | |
IPEC-J2 | 6 h | 0, 0.67, 6.7 μM | CCK-8 Assay | EC: 0.67, 6.7 μM | [160] | |
12 h | ||||||
24 h | ||||||
48 h | ||||||
72 h | ||||||
IPEC-J2 | 48 h | 0, 0.25, 0.5, 1, 2 μM | MTT Assay | LC50 = 1.83μM; EC:1–2 μM | [161] | |
IPEC-J2 | 24 h | 0, 0.43, 0.85, 1.7, 3.4, 6.7 μM | CCK-8 Assay | EC: 0.85–6.7 μM | [162] | |
ZEA | Caco-2 | 72 h | 1–150 μM | Neutral Red | LC50 = 15 μM | [155] |
MTT Assay | LC50 = 25 μM | |||||
Caco-2 | 24 h | 0, 0.001, 0.01, 0.1, 1, 10, 25, 50, 100 μM | CCK-8 | LC50 = 62.67 μM | [156] | |
48 h | LC50 = 56.96 μM | |||||
72 h | LC50 = 34.36 μM | |||||
IPEC-1 | 24 h | 0, 0.1, 1, 10, 100 μM | XTT Assay | EC: 100 μM | [163] | |
IPEC-1 | 24 h | 0, 0.1, 1, 10, 100 μM | XTT Assay | EC: 100 μM | [164] | |
0, 0.1, 1, 10, 100 μM | Neutral Red | EC: 100 μM | ||||
IPEC-J2 | 48 h | 0, 5, 10, 20, 40 μM | MTT Assay | EC: 10, 40 μM | [161] | |
IPEC-J2 | 48 h | 0, 15.5, 31, 62, 124, 248 μM | MTT Assay | LC50 = 62.1 μM; EC: 62–248 μM |
[46] | |
IPEC-J2 | 72 h | 0, 19.9, 39.8, 44.73, 59.7, 79.6, 99.5 μM | Annexin-V-FITC/PI | EC: 44.73–99.5 μM | [158] | |
Caco-2 | 24 h | 0, 0.032, 0.16, 0.32, 1.6, 3.2 μM | MTT Assay | EC: 3.2 μM | [165] | |
AFB1 | 48 h | EC: 0.32—3.2 μM | ||||
72 h | EC: 1.6–3.2 μM | |||||
Caco-2 (differentiated) | 24 h | 0, 0.032, 0.16, 0.32, 1.6, 3.2 μM | MTT Assay | EC: 1.6 μM | [165] | |
48 h | EC: 1.6–3.2 μM | |||||
72 h | EC: 0.16–3.2 μM | |||||
Caco-2 | 24 h | 0, 0.032, 0.16, 0.32, 1.6, 3.2 μM | LDH release | EC: 1.6–3.2 μM | [165] | |
48 h | EC: 0.32–3.2 μM | |||||
72 h | EC: 0.32–3.2 μM | |||||
Caco-2 (differentiated) | 24 h | 0, 0.032, 0.16, 0.32, 1.6, 3.2 μM | LDH release | EC: 3.2 μM | [165] | |
48 h | EC: 0.032–3.2 μM | |||||
72 h | EC: 0.032–3.2 μM | |||||
Caco-2 | 24 h | 0, 1,3, 10, 30, 100 μM | MTT Assay | LC50 = 5.39 μM EC: 1–100 μM |
[166] | |
LDH release | LC50 = 10 μM EC: 3–100 μM |
|||||
Caco-2 | 24 h | 0–100 μM | Neutral Red | LC50 = 10 μM | [167] | |
48 h | LC50 = 2 μM | |||||
72 h | LC50 = 0.75 μM | |||||
CIT | Caco-2 | 48 h | 0, 399.6, 999 μM | Crystal Violet staining (CVS) | EC: 399.6, 999 μM | [168] |
HCT116 | 36 h | 0, 75, 150, 300 μM | Fluorescein diacetate (FDA) staining | LC50 = 300 μM; EC: 150- 300 μM | [169] | |
MPA | Caco-2 | 48 h | 0, 0.0078, 0.078, 0.78, 7.8, 78, 780 μM | MTS Assay | LC50 > 780 uM | [75] |
Caco-2 (differentiated) | ||||||
OTA | Caco-2 | 24 h | 0, 1, 3, 10, 30, 100 μM | MTT Assay | LC50 = 21.25 μM; EC: 1–100 μM | [166] |
LDH release | LC50 = 16.85 μM; EC: 1–100 μM | |||||
Caco-2 | 24 h | 1–200 μM | MTT Assay | LC50 = 145.36 μM | [170] |